GlaxoSmithKline endorsement for TI Pharma
GlaxoSmithKline (GSK), one of the leading innovative pharmaceutical and healthcare companies in the world, regrets the decision of the Dutch government for only granting bridging finance to Top Institute Pharma (TI Pharma). The resigning cabinet passes the decision making for long-term financing on to the next cabinet. The coming 4 years TI Pharma will need public funding for 60 million Euro. The survival of this important public-private collaboration in the field of drug research is at risk with this decision.
Source: ANP Pers Support (in Dutch)